SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 367 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,551,000 | +1.3% | 9,100 | -16.5% | 0.11% | -15.9% |
| Q3 2020 | $1,531,000 | -18.4% | 10,900 | -6.8% | 0.13% | -17.5% |
| Q2 2020 | $1,876,000 | +30.5% | 11,700 | -20.4% | 0.16% | +8.8% |
| Q1 2020 | $1,438,000 | -5.6% | 14,700 | +24.6% | 0.15% | +38.7% |
| Q4 2019 | $1,523,000 | -24.6% | 11,800 | -11.3% | 0.11% | -25.4% |
| Q2 2019 | $2,021,000 | +27.5% | 13,300 | 0.0% | 0.14% | +23.5% |
| Q1 2019 | $1,585,000 | +9.2% | 13,300 | 0.0% | 0.12% | -13.5% |
| Q4 2018 | $1,451,000 | -15.2% | 13,300 | +25.5% | 0.13% | +2.3% |
| Q3 2018 | $1,712,000 | – | 10,600 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |